Insight into the effects on neural cells of the TCF4 gene mutation that causes a severe autism spectrum disorder
You don’t need to be a neuroscientist to notice the size and structural differences between these two brain organoids – cultured clumps of brain cells that replicate certain features and functions of actual brain tissue. These 'mini-brains' were generated from human stem cells and differ because of the donors. Cells from a person with Pitt-Hopkins syndrome – a severe form of autism spectrum disorder characterised by intellectual disability, developmental delay and seizures – were used to generate the organoid on the right, while cells from someone without the condition generated the one on the left. Mutations to a gene called TCF4 cause Pitt-Hopkins syndrome and studying the patient-derived organoids revealed how the mutation impairs proper growth and development of neurons. Encouragingly, mutation-fixing gene therapy performed on the mini-brains improved the cells’ development and function, providing hope that similar therapies might one day alleviate symptoms in children with this rare but debilitating condition.
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.